2025-10-21T11:49:28-05:00 2024-12-31 881478669 CBIZ ADVISORS LLC 1899 L STREET NW 850 WASHINGTON DC 20036 990 2024-01-01 510178702 RADIATION ONCOLOGY INSTITUTE RADI 7038397312 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 VIVEK S KAVADI EX-OFFICIO, EXECUTIVE DIRECTOR 7038397312 2025-10-21 1 1 AARON M FOX P01365820 2022274000 2025-10-21 2024 2025-03-06 01:10:19Z VIVEK S KAVADI 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 1751833 0 X WWW.ROINSTITUTE.ORG X 1974 IL TO ENHANCE AND PROMOTE THE CRITICAL ROLE OF RADIATION THERAPY IN THE TREATMENT OF CANCER. 11 11 0 47 0 0 306073 310990 0 0 249672 671535 -37147 1321 518598 983846 417590 330653 0 0 344592 347510 0 0 300277 254982 285804 1017164 963967 -498566 19879 16890609 18112982 83412 34717 16807197 18078265 THE RADIATION ONCOLOGY INSTITUTE'S MISSION IS TO HEIGHTEN THE CRITICAL ROLE OF RADIATION THERAPY IN THE TREATMENT OF CANCER THROUGH RESEARCH AND EDUCATION. 0 0 422358 330653 RESEARCH PROGRAM SUPPORTS BOLD AND INNOVATIVE IDEAS IN RADIATION THERAPY TO IMPROVE OUTCOMES FOR PATIENTS SO THEY CAN LIVE LONGER, HEALTHIER LIVES. ROI CATALYZES DISCOVERY IN HIGH PRIORITY AREAS OF RESEARCH FOR RADIATION ONCOLOGY BY AWARDING GRANTS TO THE BEST AND BRIGHTEST INVESTIGATORS WHO ARE WORKING TO PERSONALIZE CARE, MINIMIZE TOXICITY, IMPROVE SAFETY AND QUALITY, ADVANCE HEALTH EQUITY, AND ENHANCE PATIENT EXPERIENCE. 28930 THE ROI TOOLBOX IS A RESOURCE FOR HEALTH CARE PROFESSIONALS THAT IS DESIGNED TO SUPPORT EVIDENCE-BASED PRACTICE. THIS POINT-OF-CARE TOOL COMPILES FREQUENTLY ACCESSED REFERENCES RELATED TO THE DELIVERY OF RADIATION THERAPY, INCLUDING DOSE CONSTRAINTS, CALCULATORS, TOXICITY SCALES, AND CLINICAL PRACTICE GUIDELINES. DEL REGATO PROGRAM SUPPORTS WEBINARS FOR RESIDENTS THROUGH A PARTNERSHIP WITH THE ASSOCIATION OF RESIDENTS IN RADIATION ONCOLOGY (ARRO) AND THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO). THE LIVE WEBINARS ARE FREE OF CHARGE FOR RESIDENTS AND OFFER A UNIQUE OPPORTUNITY TO CONNECT WITH FACULTY LEADERS IN THE FIELD OF RADIATION ONCOLOGY. 451288 1 1 0 0 0 0 0 0 0 1 0 1 0 0 0 1 1 1 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 2 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 VA X X DEMELASH AYALEW 7038397312 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 RONALD CHEN RESEARCH COMMITTEE CHAIR 1.00 0.00 X 0 2000 0 JERRY JABOIN TRUSTEE 1.00 0.00 X 0 2000 0 COLLEEN A F LAWTON PRESIDENT 1.00 0.00 X X 0 0 0 GITA SUNEJA RESEARCH CMTE VICE PRESIDENT 1.00 0.00 X X 0 0 0 PHILLIP DEVLIN TREASURER 1.00 0.00 X X 0 0 0 RON DIGIAIMO TRUSTEE 1.00 0.00 X 0 0 0 JOIN Y LUH DEVELOPMENT COMMITTEE CHAIR 1.00 0.00 X 0 0 0 JASON A EFSTATHIOU TRUSTEE 1.00 0.00 X 0 0 0 DEEPAK KHUNTIA TRUSTEE 1.00 0.00 X 0 0 0 JOHN BUATTI ASTRO REPRESENTATION 1.00 2.00 X 0 0 0 GERALDINE JACOBSEN ASTRO REPRESENTATION UNTIL 10/24 1.00 2.00 X 0 0 0 JEFF MICHALSKI ASTRO REPRESENTATION AS OF 10/24 1.00 2.00 X 0 0 0 LAURA I THEVENOT EXEC DIR SECR AND ASST TREAS UNTIL 11/24 4.00 36.00 X 0 805285 69093 VIVEK S KAVADI EXEC DIR SECR AND ASST TREAS AS OF 11/24 4.00 36.00 X 0 135239 8704 0 944524 77797 0 0 1 0 0 39929 14463 256598 310990 464174 464174 970958 763597 207361 207361 207361 5606 39929 4390 1216 1216 OTHER INCOME 900099 105 105 105 983846 0 0 672856 326153 326153 3000 3000 1500 1500 347510 75746 104050 167714 17680 17680 37219 37219 41833 8784 33049 36049 3095 12525 20429 78330 20952 21058 36320 12904 308 12127 469 20549 3045 3265 14239 4395 4395 BAD DEBT EXPENSES 15000 0 0 15000 FUNDRAISING EXPENSES 12650 0 0 12650 DUES AND PUBLICATIONS 9195 8705 83 407 963967 451288 212402 300277 24859 51805 189181 460325 184719 113435 36350 93150 5970 5848 13713356 14600412 2736174 2757423 0 30584 16890609 18112982 40560 9262 33654 25455 9198 0 83412 34717 X 2721208 2810293 14085989 15267972 16807197 18078265 16890609 18112982 19879 1206452 44737 0 X 0 1 X 1 0 X 619829 422102 357251 306073 310990 2016245 619829 422102 357251 306073 310990 2016245 230432 1785813 402347 717127 326315 364068 464174 2274031 105 105 4290381 0.41620 0.41520 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 13648684 14463 1525953 301292 14887808 12126787 13519 1768305 259927 13648684 13733831 21583 -1448434 180193 12126787 12559469 12685 1343949 182272 13733831 11274198 70506 1437601 222836 12559469 0.00000 0.68540 0.31460 0 0 0 PARTNERS GROUP PRIVATE EQUITY MASTER FUND 1259043 F TA REALTY CORE PROPERTY FUND 673270 F BLACKSTONE BREIT 333259 F SKYBRIDGE MULTI-ADVISER HEDGE FUND 131604 F AG TWIN BROOK 360247 F 2757423 X 2157469 1206452 1206452 951017 37219 -4390 32829 983846 886401 -44737 4390 -40347 926748 37219 37219 963967 PART V, LINE 4: ROI INTENDS TO USE THESE ENDOWMENT FUNDS TO SUPPORT PROGRAMS THAT PROMOTE THE ACHIEVEMENT OF ITS MISSION. PART X, LINE 2: ROI PERFORMED AN EVALUATION OF UNCERTAINTY IN INCOME TAXES FOR THE YEAR ENDED DECEMBER 31, 2024, AND DETERMINED THAT THERE ARE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EVENT NET INCOME -4,390. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES 4,390. 5K RUN 45535 39929 5606 4390 45535 39929 5606 4390 4390 1216 1 UNIVERSITY HOSPITALS OF CLEVELAND 11100 EUCLID AVE CLEVELAND OH 44106 341567805 501(C)(3) 52000 0 RESEARCH AWARD BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 77030 741613878 501(C)(3) 45917 0 RESEARCH AWARD JOHNS HOPKINS UNIVERSITY 3910 KESWICH RD BALTIMORE MD 21211 520595110 501(C)(3) 44603 0 RESEARCH AWARD THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 101 MANNING DRIVE CHAPEL HILL NC 27599 566001393 501(C)(3) 35874 0 RESEARCH AWARD MAYO CLINIC 4500 SAN PABLO ROAD JACKSONVILLE FL 32224 593337028 501(C)(3) 33484 0 RESEARCH AWARD BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS ST BOSTON MA 02115 042312909 501(C)(3) 28820 0 RESEARCH AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 10889 WILSHIRE BOULEVARD LOS ANGELES CA 90095 956006143 501(C)(3) 25455 0 RESEARCH AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 3333 CALIFORNIA STREET SAN FRANCISCO CA 94143 946036493 501(C)(3) 25000 0 RESEARCH AWARD NYU SCHOOL OF MEDICINE 550 FIRST AVENUE NEW YORK NY 10016 135562308 501(C)(3) 25000 0 RESEARCH AWARD AMERICAN SOCIETY FOR RADIATION ONCOLOGY 251 18TH STREET SOUTH 8TH FLOOR ARLINGTON VA 22202 420943164 501(C)(6) 10000 0 2024 ROI SUPPORT TO ARRO WEBINAR 9 1 PART I, LINE 2: SIGNED AWARD LETTERS OUTLINE THE TERMS AND CONDITIONS OF ACCEPTANCE AND USE OF THE RESEARCH AWARD. AS PER THE SIGNED AGREEMENT, AN INTERIM PROGRESS REPORT AND A FINAL REPORT ARE COLLECTED WHICH SUMMARIZE PROGRESS MADE AND EXPENDITURES. 0 1 0 0 0 0 0 0 0 LAURA I THEVENOT EXEC DIR SECR AND ASST TREAS UNTIL 11/24 0 609347 0 124274 0 71664 0 45500 0 23593 0 874378 0 0 PART I, LINE 3 ROI DOES NOT DIRECTLY HIRE OR COMPENSATE EMPLOYEES. ALL EMPLOYEES ARE EMPLOYEES OF THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A RELATED ORGANIZATION EXEMPT UNDER SECTION 501(C)(6). AN INDEPENDENT CONSULTANT PERFORMED A MARKET SURVEY TO DEVELOP SALARY STRUCTURE AND RANGES. ASTRO'S PRACTICE IS TO COMPLETE A MARKET SURVEY EVERY THREE YEARS; THIS WAS LAST COMPLETED FOR THE EX-OFFICIO, EXECUTIVE DIRECTOR IN 2024. THE EX-OFFICIO, EXECUTIVE DIRECTOR'S COMPENSATION IS DETERMINED BY A SUBCOMMITTEE OF THE BOARD USING COMPARABLE SALARIES OF SIMILAR EXECUTIVE DIRECTOR POSITIONS OF NONPROFIT MEDICAL ORGANIZATIONS. THIS REVIEW WAS DISCUSSED WITH THE BOARD OF DIRECTORS AND THE FINAL DETERMINATION WAS MADE BY THE EXECUTIVE COMMITTEE. PART I, LINE 4B DURING THE YEAR ENDED DECEMBER 31, 2024, LAURA THEVENOT, CEO OF ASTRO UNTIL 11/24, PARTICIPATED IN A 457(F) NONQUALIFIED PLAN, WITH CONTRIBUTIONS OF THE PLAN OF $11,000. FORM 990, PART VI, SECTION A, LINE 3 ALL MANAGEMENT FUNCTIONS OF ROI ARE CONTROLLED BY THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A RELATED ORGANIZATION EXEMPT UNDER SECTION 501(C)(6). FORM 990, PART VI, SECTION B, LINE 11B THE FEDERAL FORM 990 IS PREPARED BY OUR EXTERNAL TAX ACCOUNTANTS. THE DRAFT IS PROVIDED TO OUR FINANCE STAFF FOR REVIEW BEFORE BEING SUBMITTED TO THE VP FINANCE & ADMINISTRATION, EXECUTIVE DIRECTOR, AND TREASURER OF ROI FOR THEIR REVIEW AND APPROVAL. THE REVISED DRAFT IS THEN PROVIDED TO THE FULL BOARD OF TRUSTEES PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ROI'S OFFICERS, DIRECTORS, KEY EMPLOYEES, AND VOLUNTEERS ARE REQUIRED TO FILL OUT DISCLOSURE FORMS ON AN ANNUAL BASIS AND TO UPDATE THEIR DISCLOSURE FORMS UPON ANY MATERIAL CHANGE IN THE INTERIM. THESE DISCLOSURE FORMS ARE REVIEWED IN ORDER TO IDENTIFY AND ADDRESS ANY POTENTIAL CONFLICTS OF THESE INDIVIDUALS. FORM 990, PART VI, SECTION C, LINE 19 AUDITED FINANCIAL STATEMENTS, 990 FORMS AND GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICIES ARE AVAILABLE ON OUR WEBSITE. AMERICAN SOCIETY FOR RADIATION ONCOLOGY 251 18TH STREET SOUTH 8TH FLOOR ARLINGTON VA 22202 420943164 MEMBERSHIP SOCIETY IL 501(C)(6) N/A 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 AMERICAN SOCIETY FOR RADIATION ONCOLOGY B 10000 ACTUAL AMERICAN SOCIETY FOR RADIATION ONCOLOGY C 14463 ACTUAL AMERICAN SOCIETY FOR RADIATION ONCOLOGY N 78330 FMV AMERICAN SOCIETY FOR RADIATION ONCOLOGY O 347510 FMV AMERICAN SOCIETY FOR RADIATION ONCOLOGY P 30959 ACTUAL AMERICAN SOCIETY FOR RADIATION ONCOLOGY Q 6497 ACTUAL